With the development of society, aged population is growing. Hip fracture is the most common
disease for aged people. With the life being longer than before, incidence of this disease is
growing. The mortality of this disease is high—— almost 10% patients will die within 1 month,
about 1/3 of patients will die within 12 months. About 20%-30% aged people who have hip
fracture will die within one year.
The damaged organs caused by excessive inflammatory is one of possible reasons to cause
higher mortality. Therefore, the investigators imagined that if they gave medicines to
patients in time to reduce the inflammatory level, the inflammatory might have less effects
on organs, and the recovery could be improved.
The investigators hypothesis on the basic research: the anti-inflammatory function of non
steroidal antiinflammatory drugs (NSAIDs) can inhibit the inflammatory level of elderly hip
fracture, so as to improve the recovery level and reduce the complicating disease and
mortality. The investigators designed a clinic study to research NSAIDS' effects on
inflammatory level and prognosis of elderly hip fracture.